CN1175844C

CN1175844C - Externally-applied medicine for treaitng red swelling

Info

Publication number: CN1175844C
Application number: CNB01123024XA
Authority: CN
Inventors: 介鸿勇
Original assignee: Individual
Current assignee: Individual
Priority date: 2001-07-20
Filing date: 2001-07-20
Publication date: 2004-11-17
Anticipated expiration: 2021-07-20
Also published as: CN1397292A

Abstract

The present invention discloses medicine for exterior use for treating skin soft tissue acute infective diseases. The present invention takes red sage root, bletilla striata, scutellaria root, biond magnolia flower and dahurian angelica as raw materials to prepare traditional Chinese medicine powder in order to prepare various dosage forms of the medicine for exterior use. The present invention has the advantages of short course of treatment, quick curative effect, little patient pain, low cost, no side effect and complication, etc. General patients can be cured for using the medicine once or twice.

Description

A kind of external used medicine for the treatment of the skin soft tissue acute infectious diseases

Technical field

The present invention relates to a kind of medicine for the treatment of the skin soft tissue acute infectious diseases, a kind of specifically is the medicine for external use that raw material is made with the Chinese herbal medicine.

Background technology

The skin soft tissue acute infectious diseases comprises furuncle, folliculitis, carbuncle, paronychia, lymphangitis, lymphadenitis and cellulitis, is commonly encountered diseases, the frequently-occurring disease of surgery.This disease can occur in any position of human body, and the disease sites early symptom is rubescent, swelling, scorching hot, pain, and the function of corresponding site is affected., might cause intracranial infection and cause severe complication in women's head-ornaments portion as long.Early stage in pathological changes, if can in time use active drug at affected part, a couple of days can fully recover; As can not get effective treatment in early days, gently then local suppuration, ulceration, heavy then antibacterial and toxin are gone into blood and are formed whole body severe infections such as bacteremia, toxemia, septicemia, pyemia, even septic shock can occur and threat to life.

At present, to the early treatment of skin soft tissue acute infectious diseases, usually be to use the YUSHIZHI RUANGAO external application, physical therapy, or hot compress, or 2.5% iodine tincture is put on the skin and is coated with, but weak curative effect, the course of disease is long, causes focus to can not get effective control in early days, make the inflammation diffusion, the state of an illness increases the weight of, and increases patient's misery, has prolonged the course of disease, strengthen the consumption and the time of antibiotics, also increased the weight of patient's financial burden simultaneously.

Summary of the invention

The object of the present invention is to provide a kind of pain relieving good, inflammatory resolution is fast, good effect, medicine---the externally-applied medicine for treaitng red swelling of the treatment skin soft tissue acute infectious diseases that expense is low.

Medicine of the present invention is made up of raw material of Chinese medicine Radix Salviae Miltiorrhizae, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Scutellariae, Flos Magnoliae and the Radix Angelicae Dahuricae, and each crude drug shared ratio in prescription is:

Radix Salviae Miltiorrhizae 8-20% Pseudobulbus Bletillae (Rhizoma Bletillae) 20-35% Radix Scutellariae 10-25%

Flos Magnoliae 15-30% Radix Angelicae Dahuricae 10-35%

Crude drug of the present invention shared optimal proportion in prescription is:

Radix Salviae Miltiorrhizae 12.5% Pseudobulbus Bletillae (Rhizoma Bletillae) 25% Radix Scutellariae 12.5%

Flos Magnoliae 25% Radix Angelicae Dahuricae 25%

Medicine externally-applied medicine for treaitng red swelling of the present invention is to manufacture with conventional method to form:

Earlier the above Chinese medicine of respectively distinguishing the flavor of is made Chinese medicinal powder, after the Chinese medicine of respectively distinguishing the flavor of more than being about to was rejected impurity respectively, water cleaned up respectively, places drying baker to dry, and in the above ratio mixing of weighing, pulverized mistake 80 mesh sieve fine powders, the airtight preservation of the container of packing into through pulverizer again; Be raw material with the Chinese medicinal powder again, make the various dosage forms of medicine for external use.

Medicine externally-applied medicine for treaitng red swelling of the present invention, clinical effectiveness to treatment skin soft tissue acute infectious diseases shows, it has following advantage: good analgesic effect, inflammatory resolution is fast, the patient suffering is few, short treating period, good effect, treatment are conveniently, can effectively control the generation of later stage symptom, pollution clothes not, expense is low, and any side effect and complication are not arranged.

For showing the therapeutic effect of medicine externally-applied medicine for treaitng red swelling of the present invention, the clinical effectiveness of the various case 516 routine test group of this human therapy has been made statistics, and the therapeutic outcome of 886 routine matched groups of corresponding disease has been made statistics the skin soft tissue acute infectious diseases.Adopt the clinical using method of medicine externally-applied medicine for treaitng red swelling 516 routine test group of the present invention to be: Chinese medicinal powder and diluent are restrained in 1000: the ratio weighing of 1800-2000 milliliter is good, diluent slowly injected fill in the container of Chinese medicinal powder, it is airtight standby to make paste-redness paste that disappears after stirring.Cover the red and swollen thickness of distinguishing 1 millimeter with this paste, preserve moisture with plastic fresh-keeping membrane, fixing with adhesive plaster or gauze wrapping.Every day 1 time, 1-2 pathological changes of the drug of topical application more shallow person can fully recover, the dark corresponding increase of person's medication number of times of pathological changes, and 7 red and swollen heat pain complete obiterations of medication and fully recovering at most, clinical effectiveness sees Table 1.The clinical using method of 886 routine matched groups is: cover the red and swollen thickness of distinguishing 1 millimeter with YUSHIZHI RUANGAO, and fixing with adhesive plaster or gauze wrapping.Every day 1 time, clinical effectiveness sees Table 2.

Test group is consistent with the criterion of cure of matched group, all is meant the red and swollen heat pain transference cure.If any General Symptoms, disappear through the treatment General Symptoms.

The table 1 redness paste treatment skin soft tissue acute infectious diseases curative effect catalog that disappears

The sick kind	Treat routine number	The redness paste drug of topical application number of times that disappears				1-2 red and swollen dissipation rate of the drug of topical application	The smelting standard that heals
								1-2	3-4	5-6	More than 7 times
		Furuncle (folliculitis) carbuncle paronychia angioleucitis lymphnoditis cellulitis adds up to	158 81 26 65 102 84 516	150 65 22 58 89 67 451	8 13 4 7 10 11 53			1-2	3-4	5-6	More than 7 times	3 3 5 11	1	94.9％ 80.2％ 84.6％ 89.2％ 87.2％ 79.8％ 87.4％	Local red and swollen heat pain dissipates if any General Symptoms, disappears through the treatment General Symptoms

Table 2 YUSHIZHI RUANGAO external application for curing skin soft tissue acute infectious diseases curative effect catalog

The sick kind	Treat routine number	YUSHIZHI RUANGAO drug of topical application number of times				1-2 red and swollen dissipation rate of the drug of topical application	The smelting standard that heals
								1-2	3-4	5-6	More than 7 times
		Furuncle (folliculitis) carbuncle paronychia angioleucitis lymphnoditis cellulitis adds up to	358 106 88 62 108 164 886	18 2 3 5 6 3 37	41 2 18 13 17 8 99			1-2	3-4	5-6	More than 7 times	4 15 14 33	5.0％ 1.8％ 3.4％ 8.1％ 5.6％ 1.8％ 4.2％	Local red and swollen heat pain dissipates if any General Symptoms, disappears through the treatment General Symptoms

From table one and table two as can be seen:

Use the test group of Drug therapy of the present invention, 1-2 red and swollen heat pain dissipation of drug of topical application rate is 87.4%, uses the matched group of YUSHIZHI RUANGAO treatment, and 1-2 red and swollen heat pain dissipation of drug of topical application rate only is 4.2%.The early treatment's effect that is test group is higher than matched group far away.His-and-hers watches 1 and table 2 are further analyzed as can be known: the medicine drug of topical application of the present invention is 99.81% with interior red and swollen heat pain dissipation rate 6 times, is 19.07% with interior red and swollen heat pain dissipation rate 6 times with the YUSHIZHI RUANGAO drug of topical application.

The specific embodiment

Embodiment 1: after Radix Salviae Miltiorrhizae, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Scutellariae, Flos Magnoliae and the remove impurity of Radix Angelicae Dahuricae difference, water cleans up respectively, places drying baker to dry.Take by weighing Radix Salviae Miltiorrhizae 80 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 200 grams, Radix Scutellariae 100 grams, Flos Magnoliae 280 grams and the Radix Angelicae Dahuricae 340 gram mixings, pulverize, cross 80 mesh sieve fine powders, make Chinese medicinal powder 1000 grams, the container of packing into through pulverizer.Measure 1700 milliliters of medical salines, slowly inject the container that fills Chinese medicinal powder, sealing stirs.

Embodiment 2: after Radix Salviae Miltiorrhizae, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Scutellariae, Flos Magnoliae and the remove impurity of Radix Angelicae Dahuricae difference, water cleans up respectively, places drying baker to dry.Take by weighing Radix Salviae Miltiorrhizae 170 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 300 grams, Radix Scutellariae 150 grams, Flos Magnoliae 180 grams and the Radix Angelicae Dahuricae 200 gram mixings, pulverize, cross 80 mesh sieve fine powders, make Chinese medicinal powder 1000 grams, the container of packing into through pulverizer.Measure 1800 milliliters of 0.1% acetums, slowly inject the container that fills Chinese medicinal powder, sealing stirs.

Claims

1, a kind of external used medicine for the treatment of the skin soft tissue acute infectious diseases is characterized in that being made up of the Chinese medicinal powder raw material of following weight percentage ratio: Radix Salviae Miltiorrhizae 8-20% Pseudobulbus Bletillae (Rhizoma Bletillae) 20-35% Radix Scutellariae 10-25% Flos Magnoliae 15-30% Radix Angelicae Dahuricae 10-35%.

2, a kind of external used medicine for the treatment of the skin soft tissue acute infectious diseases according to claim 1 is characterized in that the percentage by weight of Chinese medicinal powder raw material is: Radix Salviae Miltiorrhizae 12.5% Pseudobulbus Bletillae (Rhizoma Bletillae) 25% Radix Scutellariae 12.5% Flos Magnoliae 25% Radix Angelicae Dahuricae 25%.